Melatonin in the eye: Implications for glaucoma

Experimental Eye Research

Volumn 84, Issue 6, 2007, Pages 1021-1030

  Lundmark, Per O ^a   Pandi Perumal, S R ^b   Srinivasan, V ^c   Cardinali, D P ^d   Rosenstein, R E ^d  

^a UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

antioxidant properties; free radicals; glaucoma; glutamate excitotoxicity; intraocular pressure; melatonin

Indexed keywords

ALPHA TOCOPHEROL; BETAXOLOL; BRIMONIDINE; CALCIUM CHANNEL BLOCKING AGENT; GINKGO BILOBA EXTRACT; GLUTAMIC ACID; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; MEMANTINE; NITRIC OXIDE; SCAVENGER; UBIQUINONE;

ANTIOXIDANT ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; EXCITOTOXICITY; GLAUCOMA; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; INTRAOCULAR PRESSURE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VISUAL ACUITY;

ANIMALS; ANTIOXIDANTS; EYE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MELATONIN; OXIDATIVE STRESS; RECEPTORS, MELATONIN;

EID: 34249071601     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.10.018     Document Type: Review

References (138)

1. Acuña-Castroviejo D., Escames G., Carazo A., Leon J., Khaldy H., and Reiter R.J. Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr. Top. Med. Chem. 2 (2002) 133-151
2. Alder V.A., and Cringle S.J. The effect of the retinal circulation on vitreal oxygen tension. Curr. Eye Res. 4 (1985) 121-129
3. Alonso-Gomez A.L., and Iuvone P.M. Melatonin biosynthesis in cultured chick retinal photoreceptor cells: calcium and cyclic AMP protect serotonin N-acetyltransferase from inactivation in cycloheximide-treated cells. J. Neurochem. 65 (1995) 1054-1060
4. Avery R.L., Fekrat S., Hawkins B.S., and Bressler N.M. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 16 (1996) 183-189
5. Bailey M.J., Chong N.W., Xiong J., and Cassone V.M. Chicken's Cry2: molecular analysis of an avian cryptochrome in retinal and pineal photoreceptors. FEBS Lett. 513 (2002) 169-174
6. Benozzi J., Nahum L.P., Campanelli J.L., and Rosenstein R.E. Effect of hyaluronic acid on intraocular pressure in rats. Investig. Ophthalmol. Vis. Sci. 43 (2002) 2196-2200
7. Bernard M., Guerlotte J., Greve P., Grechez-Cassiau A., Iuvone M.P., Zatz M., Chong N.W., Klein D.C., and Voisin P. Melatonin synthesis pathway: circadian regulation of the genes encoding the key enzymes in the chicken pineal gland and retina. Reprod. Nutr. Dev. 39 (1999) 325-334
8. Brainard G.C., Hanifin J.P., Greeson J.M., Byrne B., Glickman G., Gerner E., and Rollag M.D. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J. Neurosci. 21 (2001) 6405-6412
9. Brainard G.C., Hanifin J.P., Rollag M.D., Greeson J., Byrne B., Glickman G., Gerner E., and Sanford B. Human melatonin regulation is not mediated by the three cone photopic visual system. J. Clin. Endocrinol. Metab. 86 (2001) 433-436
10. Bubenik G.A., and Purtill R.A. The role of melatonin and dopamine in retinal physiology. Can. J. Physiol. Pharmacol. 58 (1980) 1457-1462
11. Bunin A.I., Filina A.A., and Erichev V.P. A glutathione deficiency in open-angle glaucoma and the approaches to its correction. Vestn. Oftalmol. 108 (1992) 13-15
12. Cahill G.M., and Besharse J.C. Circadian clock functions localized in Xenopus retinal photoreceptors. Neuron 10 (1993) 573-577
13. Cai J., Nelson K.C., Wu M., Sternberg Jr. P., and Jones D.P. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res. 19 (2000) 205-221
14. Cardinali D.P., and Rosner J.M. Metabolism of serotonin by the rat retina "in vitro". J. Neurochem. 18 (1971) 1769-1770
15. Cardinali D.P., and Rosner J.M. Retinal localization of the hydroxyindole-O-methyl transferase (HIOMT) in the rat. Endocrinology 89 (1971) 301-303
16. Chan D.K., Lim M.S., Choo S.H., and Tan I.K. Vitamin E status of infants at birth. J. Perinatal. Med. 27 (1999) 395-398
17. Chew S.J., and Ritch R. Neuroprotection: the next breakthrough in glaucoma? Proceedings of the third annual optic nerve rescue and restoration think tank. J. Glaucoma 6 (1997) 263-266
18. Ciuffi M., Pisanello M., Pagliai G., Raimondi L., Franchi-Micheli S., Cantore M., Mazzetti L., and Failli P. Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure. J. Photochem. Photobiol. B Biol. 71 (2003) 59-68
19. Claustrat B., Brun J., and Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med. Rev. 9 (2005) 11-24
20. Cruickshanks K.J., Klein R., and Klein B.E. Sunlight and age-related macular degeneration. The Beaver Dam eye study. Arch. Ophthalmol. 111 (1993) 514-518
21. Cruickshanks K.J., Klein R., Klein B.E., and Nondahl D.M. Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. Arch. Ophthalmol. 119 (2001) 246-250
22. Dinet V., Girard-Naud N., Voisin P., and Bernard M. Melatoninergic differentiation of retinal photoreceptors: activation of the chicken hydroxyindole-O-methyltransferase promoter requires a homeodomain-binding element that interacts with Otx2. Exp. Eye Res. 83 (2006) 276-290
23. Dorey C.K., Delori F.C., and Akeo K. Growth of cultured RPE and endothelial cells is inhibited by blue light but not green or red light. Curr. Eye Res. 9 (1990) 549-559
24. Doyle S.E., Grace M.S., McIvor W., and Menaker M. Circadian rhythms of dopamine in mouse retina: the role of melatonin. Vis. Neurosci. 19 (2002) 593-601
25. Dreyer E.B., Pan Z.H., Storm S., and Lipton S.A. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport 5 (1994) 629-631
26. Dreyer E.B., Zurakowski D., Schumer R.A., Podos S.M., and Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114 (1996) 299-305
27. Dubocovich M.L., Cardinali D.P., Delagrange P., Krause D.N., Strosberg D., Sugden D., and Yocca F.D. Melatonin receptors. In: IUPHAR (Ed). The IUPHAR Compendium of Receptor Characterization and Classification. second ed. (2000), IUPHAR Media, London 271-277
28. 1 presynaptic heteroreceptor. Naunyn Schmiedeberg's Arch. Pharmacol. 355 (1997) 365-375
29. 125I] iodomelatonin to characterize melatonin binding sites in chicken retina. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3916-3920
30. Foster R.G., and Hankins M.W. Non-rod, non-cone photoreception in the vertebrates. Prog. Retin. Eye Res. 21 (2002) 507-527
31. Frampton P., Da Rin D., and Brown B. Diurnal variation of intraocular pressure and the overriding effects of sleep. Am. J. Optom. Physiol. Opt. 64 (1987) 54-61
32. Fujieda H., Hamadanizadeh S.A., Wankiewicz E., Pang S.F., and Brown G.M. Expression of mt1 melatonin receptor in rat retina: evidence for multiple cell targets for melatonin. Neuroscience 93 (1999) 793-799
33. 1 melatonin receptor in guinea pig retina. Vis. Neurosci. 17 (2000) 63-70
34. Fukuhara C., Dirden J.C., and Tosini G. Photic regulation of melatonin in rat retina and the role of proteasomal proteolysis. Neuroreport 12 (2001) 3833-3837
35. Fukuhara C., Liu C., Ivanova T.N., Chan G.C., Storm D.R., Iuvone P.M., and Tosini G. Gating of the cAMP signaling cascade and melatonin synthesis by the circadian clock in mammalian retina. J. Neurosci. 24 (2004) 1803-1811
36. 2+-dependent induction of serotonin N-acetyltransferase activity. Neurochem. Int. 27 (1995) 147-155
37. Garbarino-Pico E., Carpentieri A.R., Contin M.A., Sarmiento M.I., Brocco M.A., Panzetta P., Rosenstein R.E., Caputto B.L., and Guido M.E. Retinal ganglion cells are autonomous circadian oscillators synthesizing N-acetylserotonin during the day. J. Biol. Chem. 279 (2004) 51172-51181
38. Green W.R., and Key III S.N. Senile macular degeneration: a histopathologic study. Trans. Am. Ophthalmol. Soc. 75 (1977) 180-254
39. Greve P., Alonso-Gomez A., Bernard M., Ma M., Haque R., Klein D.C., and Iuvone P.M. Serotonin N-acetyltransferase mRNA levels in photoreceptor-enriched chicken retinal cell cultures: elevation by cyclic AMP. J. Neurochem. 73 (1999) 1894-1900
40. Guenther A.L., Schmidt S.I., Laatsch H., Fotso S., Ness H., Ressmeyer A.R., Poeggeler B., and Hardeland R. Reactions of the melatonin metabolite AMK (N-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J. Pineal Res. 39 (2005) 251-260
41. Hamm H.E., and Menaker M. Retinal rhythms in chicks: circadian variation in melatonin and serotonin N-acetyltransferase activity. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 4998-5002
42. Hammond Jr. B.R., Wooten B.R., and Snodderly D.M. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vis. Res. 36 (1996) 3003-3009
43. Haque R., Chaurasia S.S., Wessel III J.H., and Iuvone P.M. Dual regulation of cryptochrome 1 mRNA expression in chicken retina by light and circadian oscillators. Neuroreport 13 (2002) 2247-2251
44. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27 (2005) 119-130
45. Hardeland R., Balzer I., Poeggeler B., Fuhrberg B., Uria H., Behrmann G., Wolf R., Meyer T.J., and Reiter R.J. On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J. Pineal Res. 18 (1995) 104-111
46. Hardeland R., Pandi-Perumal S.R., and Cardinali D.P. Melatonin. Int. J. Biochem. Cell Biol. 38 (2006) 313-316
47. Isorna E., Guijarro A., Jesus D.M., Alonso-Bedate M., and Alonso-Gomez A.L. Characterization of melatonin binding sites in the brain and retina of the frog Rana perezi. Gen. Comp. Endocrinol. 135 (2004) 259-267
48. Iuvone P.M., Brown A.D., Haque R., Weller J., Zawilska J.B., Chaurasia S.S., Ma M., and Klein D.C. Retinal melatonin production: role of proteasomal proteolysis in circadian and photic control of arylalkylamine N-acetyltransferase. Investig. Ophthalmol. Vis. Sci. 43 (2002) 564-572
49. 125I]iodomelatonin binding site. J. Neurochem. 64 (1995) 1892-1895
50. Ivanova T.N., and Michael I.P. Melatonin synthesis in retina: circadian regulation of arylalkylamine N-acetyltransferase activity in cultured photoreceptor cells of embryonic chicken retina. Brain Res. 973 (2003) 56-63
51. Kaushik S., Pandav S.S., and Ram J. Neuroprotection in glaucoma. J. Postgrad. Med. 49 (2003) 90-95
52. Kitazawa Y., and Horie T. Diurnal variation of intraocular pressure in primary open-angle glaucoma. Am. J. Ophthalmol. 79 (1975) 557-566
53. Klein B.E., and Klein R. Cataracts and macular degeneration in older Americans. Arch. Ophthalmol. 100 (1982) 571-573
54. Kvetnoy I. Extrapineal melatonin in pathology: new perspectives for diagnosis, prognosis and treatment of illness. Neuroendocrinol. Lett. 23 Suppl. 1 (2002) 92-96
55. Lee P.Y., Podos S.M., Serle J.B., Camras C.B., and Severin C.H. Intraocular pressure effects of multiple doses of drugs applied to glaucomatous monkey eyes. Arch. Ophthalmol. 105 (1987) 249-252
56. Leon J., Acuña-Castroviejo D., Sainz R.M., Mayo J.C., Tan D.X., and Reiter R.J. Melatonin and mitochondrial function. Life Sci. 75 (2004) 765-790
57. Liang F.Q., and Godley B.F. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp. Eye Res. 76 (2003) 397-403
58. Liang F.Q., Green L., Wang C., Alssadi R., and Godley B.F. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp. Eye Res. 78 (2004) 1069-1075
59. Liu C., Fukuhara C., Wessel III J.H., Iuvone P.M., and Tosini G. Localization of Aa-nat mRNA in the rat retina by fluorescence in situ hybridization and laser capture microdissection. Cell Tissue Res. 315 (2004) 197-201
60. Liu J.H., and Dacus A.C. Endogenous hormonal changes and circadian elevation of intraocular pressure. Investig. Ophthalmol. Vis. Sci. 32 (1991) 496-500
61. Lundmark, P.O., Pandi-Perumal, S.R., Srinivasan, V., Cardinali, D.P. Role of melatonin in the eye and ocular dysfunctions. Vis. Neurosci., in press.
62. Marchiafava P.L., and Longoni B. Melatonin as an antioxidant in retinal photoreceptors. J. Pineal Res. 26 (1999) 184-189
63. Martin X.D., Malina H.Z., Brennan M.C., Hendrickson P.H., and Lichter P.R. The ciliary body - the third organ found to synthesize indoleamines in humans. Eur. J. Ophthalmol. 2 (1992) 67-72
64. Meyer P., Pache M., Loeffler K.U., Brydon L., Jockers R., Flammer J., Wirz-Justice A., and Savaskan E. Melatonin MT-1-receptor immunoreactivity in the human eye. Br. J. Ophthalmol. 86 (2002) 1053-1057
65. Mhatre M.C., van Jaarsveld A.S., and Reiter R.J. Melatonin in the lacrimal gland: first demonstration and experimental manipulation. Biochem. Biophys. Res. Commun. 153 (1988) 1186-1192
66. Militante J., and Lombardini J.B. Age-related retinal degeneration in animal models of aging: possible involvement of taurine deficiency and oxidative stress. Neurochem. Res. 29 (2004) 151-160
67. Moore C.G., Johnson E.C., and Morrison J.C. Circadian rhythm of intraocular pressure in the rat. Curr. Eye Res. 15 (1996) 185-191
68. Moore R.Y. Circadian rhythms: basic neurobiology and clinical applications. Annu. Rev. Med. 48 (1997) 253-266
69. Moreno M.C., Campanelli J., Sande P., Sanez D.A., Keller Sarmiento M.I., and Rosenstein R.E. Retinal oxidative stress induced by high intraocular pressure. Free Radic. Biol. Med. 37 (2004) 803-812
70. Moreno M.C., Marcos H.J., Oscar C.J., Sande P.H., Campanelli J., Jaliffa C.O., Benozzi J., and Rosenstein R.E. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Exp. Eye Res. 81 (2005) 71-80
71. Moreno M.C., Sande P., Marcos H.A., de Zavalia N., Keller Sarmiento M.I., and Rosenstein R.E. Effect of glaucoma on the retinal glutamate/glutamine cycle activity. FASEB J. 19 (2005) 1161-1162
72. Namihira M., Honma S., Abe H., Masubuchi S., Ikeda M., and Honmaca K. Circadian pattern, light responsiveness and localization of rPer1 and rPer2 gene expression in the rat retina. Neuroreport 12 (2001) 471-475
73. Natesan A.K., and Cassone V.M. Melatonin receptor mRNA localization and rhythmicity in the retina of the domestic chick, Gallus domesticus. Vis. Neurosci. 19 (2002) 265-274
74. Netland P.A., Chaturvedi N., and Dreyer E.B. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am. J. Ophthalmol. 115 (1993) 608-613
75. Neufeld A.H. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res. Bull. 62 (2004) 455-459
76. Neufeld A.H., Hernandez M.R., and Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol. 115 (1997) 497-503
77. Niki T., Hamada T., Ohtomi M., Sakamoto K., Suzuki S., Kako K., Hosoya Y., Horikawa K., and Ishida N. The localization of the site of arylalkylamine N-acetyltransferase circadian expression in the photoreceptor cells of mammalian retina. Biochem. Biophys. Res. Commun. 248 (1998) 115-120
78. Nohl H., Gille L., and Staniek K. Intracellular generation of reactive oxygen species by mitochondria. Biochem. Pharmacol. 69 (2005) 719-723
79. 3 as the quinone reductase 2. J. Biol. Chem. 275 (2000) 31311-31317
80. 2. Biochem. Pharmacol. 61 (2001) 1369-1379
81. Osborne N.N. Serotonin and melatonin in the iris/ciliary processes and their involvement in intraocular pressure. Acta Neurobiol. Exp. (Wars) 54 Suppl. (1994) 57-64
82. Osborne N.N., and Chidlow G. The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye. Exp. Eye Res. 59 (1994) 3-9
83. Osborne N.N., Chidlow G., Nash M.S., and Wood J.P. The potential of neuroprotection in glaucoma treatment. Curr. Opin. Ophthalmol. 10 (1999) 82-92
84. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J.M., Cardinali D.P., Poeggeler B., and Hardeland R. Melatonin: nature's most versatile biological signal?. FEBS J. 273 (2006) 2813-2838
85. Pang S.F., Yu H.S., Suen H.C., and Brown G.M. Melatonin in the retina of rats: a diurnal rhythm. J. Endocrinol. 87 (1980) 89-93
86. Papp A., Nemeth I., Karg E., and Papp E. Glutathione status in retinopathy of prematurity. Free Radic. Biol. Med. 27 (1999) 738-743
87. Pierce M.E., and Besharse J.C. Circadian regulation of retinomotor movements. I. Interaction of melatonin and dopamine in the control of cone length. J. Gen. Physiol. 86 (1985) 671-689
88. 3 receptors in the regulation of intraocular pressure in rabbits. Eur. J. Pharmacol. 416 (2001) 251-254
89. Rada J.A., and Wiechmann A.F. Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation. Investig. Ophthalmol. Vis. Sci. 47 (2006) 25-33
90. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56 (1998) 359-384
91. Reiter R.J., Carneiro R.C., and Oh C.S. Melatonin in relation to cellular antioxidative defense mechanisms. Horm. Metab. Res. 29 (1997) 363-372
92. 1b melatonin receptor. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8734-8738
93. Ritch R. Neuroprotection: is it already applicable to glaucoma therapy?. Curr. Opin. Ophthalmol. 11 (2000) 78-84
94. Rufiange M., Dumont M., and Lachapelle P. Correlating retinal function with melatonin secretion in subjects with an early or late circadian phase. Investig. Ophthalmol. Vis. Sci. 43 (2002) 2491-2499
95. Saenz D.A., Turjanski A.G., Sacca G.B., Marti M., Doctorovich F., Sarmiento M.I., Estrin D.A., and Rosenstein R.E. Physiological concentrations of melatonin inhibit the nitridergic pathway in the Syrian hamster retina. J. Pineal Res. 33 (2002) 31-36
96. Samples J.R., Krause G., and Lewy A.J. Effect of melatonin on intraocular pressure. Curr. Eye Res. 7 (1988) 649-653
97. 1 receptor immunoreactivity in human retina. J. Histochem. Cytochem. 50 (2002) 519-526
98. 1 melatonin receptor in the human retina: expression and localization. Investig. Ophthalmol. Vis. Sci. 43 (2002) 889-897
99. 1 melatonin receptor in human and macaque retina. Exp. Eye Res. 77 (2003) 375-382
100. Serle J.B., Podos S.M., Kitazawa Y., and Wang R.F. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn. J. Ophthalmol. 42 (1998) 95-100
101. 3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. J. Glaucoma 13 (2004) 385-388
102. Shareef S., Sawada A., and Neufeld A.H. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Investig. Ophthalmol. Vis. Sci. 40 (1999) 2884-2891
103. Siliprandi R., Canella R., Carmignoto G., Schiavo N., Zanellato A., Zanoni R., and Vantini G. N-methyl-d-aspartate-induced neurotoxicity in the adult rat retina. Vis. Neurosci. 8 (1992) 567-573
104. Siu A.W., Leung M.C., To C.H., Siu F.K., Ji J.Z., and So K.F. Total retinal nitric oxide production is increased in intraocular pressure-elevated rats. Exp. Eye Res. 75 (2002) 401-406
105. Siu A.W., Maldonado M., Sanchez-Hidalgo M., Tan D.X., and Reiter R.J. Protective effects of melatonin in experimental free radical-related ocular diseases. J. Pineal Res. 40 (2006) 101-109
106. Siu A.W., Reiter R.J., and To C.H. Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J. Pineal Res. 27 (1999) 122-128
107. Smith S.D., and Gregory D.S. A circadian rhythm of aqueous flow underlies the circadian rhythm of IOP in NZW rabbits. Investig. Ophthalmol. Vis. Sci. 30 (1989) 775-778
108. Srinivasan V., Pandi-Perumal S.R., Maestroni G.J., Esquifino A.I., Hardeland R., and Cardinali D.P. Role of melatonin in neurodegenerative diseases. Neurotoxicol. Res. 7 (2005) 293-318
109. Srinivasan V., Pandi-Perumal S.R., Poeggeler B., and Hardeland R. Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behav. Brain Funct. 2 (2006) 15
110. Sucher N.J., Lei S.Z., and Lipton S.A. Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 551 (1991) 297-302
111. Sugawara T., Sieving P.A., Iuvone P.M., and Bush R.A. The melatonin antagonist luzindole protects retinal photoreceptors from light damage in the rat. Investig. Ophthalmol. Vis. Sci. 39 (1998) 2458-2465
112. Tan D.X., Chen B., Poeggeler B., Manchester L.C., and Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1 (1993) 57-60
113. Tan D.X., Hardeland R., Manchester L.C., Poeggeler B., Lopez-Burillo S., Mayo J.C., Sainz R.M., and Reiter R.J. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J. Pineal Res. 34 (2003) 249-259
114. Thompson C.L., Selby C.P., Partch C.L., Plante D.T., Thresher R.J., Araujo F., and Sancar A. Further evidence for the role of cryptochromes in retinohypothalamic photoreception/phototransduction. Brain Res. Mol. Brain Res. 122 (2004) 158-166
115. Tosini G. Melatonin circadian rhythm in the retina of mammals. Chronobiol. Int. 17 (2000) 599-612
116. Tosini G., and Menaker M. Circadian rhythms in cultured mammalian retina. Science 272 (1996) 419-421
117. Tosini G., and Menaker M. The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration. Brain Res. 789 (1998) 221-228
118. 2+ channels. Mol. Vis. 5 (1999) 1
119. Viggiano S.R., Koskela T.K., Klee G.G., Samples J.R., Arnce R., and Brubaker R.F. The effect of melatonin on aqueous humor flow in humans during the day. Ophthalmology 101 (1994) 326-331
120. Vorwerk C.K., Lipton S.A., Zurakowski D., Hyman B.T., Sabel B.A., and Dreyer E.B. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Investig. Ophthalmol. Vis. Sci. 37 (1996) 1618-1624
121. Wang R.F., Serle J.B., Podos S.M., and Sugrue M.F. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys. Arch. Ophthalmol. 108 (1990) 511-513
122. Wang R.F., Serle J.B., Podos S.M., and Surgrue M.F. The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys. Curr. Eye Res. 9 (1990) 163-168
123. Weinreb R.N., and Levin L.A. Is neuroprotection a viable therapy for glaucoma?. Arch. Ophthalmol. 117 (1999) 1540-1544
124. Wiechmann A.F. Melatonin: parallels in pineal gland and retina. Exp. Eye Res. 42 (1986) 507-527
125. Wiechmann A.F., Campbell L.D., and Defoe D.M. Melatonin receptor RNA expression in Xenopus retina. Brain Res. Mol. Brain Res. 63 (1999) 297-303
126. Wiechmann A.F., and O'Steen W.K. Melatonin increases photoreceptor susceptibility to light-induced damage. Investig. Ophthalmol. Vis. Sci. 33 (1992) 1894-1902
127. Wiechmann A.F., and Rada J.A. Melatonin receptor expression in the cornea and sclera. Exp. Eye Res. 77 (2003) 219-225
128. Wiechmann A.F., and Smith A.R. Melatonin receptor RNA is expressed in photoreceptors and displays a diurnal rhythm in Xenopus retina. Brain Res. Mol. Brain Res. 91 (2001) 104-111
129. 1b melatonin receptor-like immunoreactivity in ocular tissues of Xenopus laevis. Exp. Eye Res. 79 (2004) 585-594
130. 1c melatonin receptor in transgenic Xenopus laevis retina. Investig. Ophthalmol. Vis. Sci. 44 (2003) 4522-4531
131. Wiechmann A.F., and Wirsig-Wiechmann C.R. Localization and quantification of high-affinity melatonin binding sites in Rana pipiens retina. J. Pineal Res. 10 (1991) 174-179
132. Wiechmann A.F., and Wirsig-Wiechmann C.R. Melatonin receptor distribution in the brain and retina of a lizard, Anolis carolinensis. Brain Behav. Evol. 43 (1994) 26-33
133. Wiechmann A.F., and Wirsig-Wiechmann C.R. Multiple cell targets for melatonin action in Xenopus laevis retina: distribution of melatonin receptor immunoreactivity. Vis. Neurosci. 18 (2001) 695-702
134. Witkovsky P., Veisenberger E., LeSauter J., Yan L., Johnson M., Zhang D.Q., McMahon D., and Silver R. Cellular location and circadian rhythm of expression of the biological clock gene Period 1 in the mouse retina. J. Neurosci. 23 (2003) 7670-7676
135. Yi C., Pan X., Yan H., Guo M., and Pierpaoli W. Effects of melatonin in age-related macular degeneration. Ann. N.Y. Acad. Sci. 1057 (2005) 384-392
136. Yu H.S., Yee R.W., Howes K.A., and Reiter R.J. Diurnal rhythms of immunoreactive melatonin in the aqueous humor and serum of male pigmented rabbits. Neurosci. Lett. 116 (1990) 309-314
137. Zawilska J., and Nowak J.Z. Melatonin in the retina of vertebrates. Acta Physiol. Pol. 40 Suppl. 33 (1989) 28-96
138. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell. Mol. Neurobiol. 21 (2001) 605-616